Guangzhou LBP Medicine Science & Technology Co Ltd (SHG:688393) — Market Cap & Net Worth
Market Cap & Net Worth: Guangzhou LBP Medicine Science & Technology Co Ltd (688393)
Guangzhou LBP Medicine Science & Technology Co Ltd (SHG:688393) has a market capitalization of $257.54 Million (CN¥1.76 Billion) as of August 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #15538 globally and #4559 in its home market, demonstrating a 11.70% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangzhou LBP Medicine Science & Technology Co Ltd's stock price CN¥18.81 by its total outstanding shares 93567699 (93.57 Million). See Guangzhou LBP Medicine Science & Technol capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Guangzhou LBP Medicine Science & Technology Co Ltd Market Cap History: 2020 to 2026
Guangzhou LBP Medicine Science & Technology Co Ltd's market capitalization history from 2020 to 2026. Data shows change from $489.17 Million to $257.54 Million (-17.31% CAGR).
Guangzhou LBP Medicine Science & Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangzhou LBP Medicine Science & Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.50x
Guangzhou LBP Medicine Science & Technology Co Ltd's market cap is 0.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
11.13x
Guangzhou LBP Medicine Science & Technology Co Ltd's market cap is 11.13 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $489.17 Million | $375.43 Million | $84.75 Million | 1.30x | 5.77x |
| 2021 | $405.91 Million | $438.99 Million | $79.78 Million | 0.92x | 5.09x |
| 2022 | $296.81 Million | $507.38 Million | $29.33 Million | 0.58x | 10.12x |
| 2023 | $338.83 Million | $497.29 Million | $40.06 Million | 0.68x | 8.46x |
| 2024 | $237.01 Million | $470.79 Million | $21.29 Million | 0.50x | 11.13x |
Competitor Companies of 688393 by Market Capitalization
Companies near Guangzhou LBP Medicine Science & Technology Co Ltd in the global market cap rankings as of August 7, 2026.
Key companies related to Guangzhou LBP Medicine Science & Technology Co Ltd by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #177 globally with a market cap of $132.88 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #281 globally with a market cap of $92.81 Billion USD ( €79.39 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #345 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #534 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.88 Billion | $375.20 |
| #281 | EssilorLuxottica S. A. | PA:EL | $92.81 Billion | €171.45 |
| #345 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €84.50 |
| #534 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Guangzhou LBP Medicine Science & Technology Co Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Guangzhou LBP Medicine Science & Technology Co Ltd's market cap moved from $489.17 Million to $ 257.54 Million, with a yearly change of -17.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥257.54 Million | -20.60% |
| 2025 | CN¥324.36 Million | +36.86% |
| 2024 | CN¥237.01 Million | -30.05% |
| 2023 | CN¥338.83 Million | +14.15% |
| 2022 | CN¥296.81 Million | -26.88% |
| 2021 | CN¥405.91 Million | -17.02% |
| 2020 | CN¥489.17 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Guangzhou LBP Medicine Science & Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $257.54 Million USD |
| MoneyControl | $257.54 Million USD |
| MarketWatch | $257.54 Million USD |
| marketcap.company | $257.54 Million USD |
| Reuters | $257.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase… Read more